Welcome to Acidity Regulator Quarterly China Report-Q1 2025
Citric acid industry:
In 2024, Shandong Ensign achieved a 1.48% increase in revenue, an 8.34% rise in net profit, an improvement in gross margin and a 19.87% expansion in total assets.
Lactic acid (LA) industry:
In 2024, Jindan Technology's revenue reached USD210.38 million, a 6.15% increase, while net profit dipped to USD5.22 million, down 56.01%.
Succinic acid and Malic Acid industry:
Huaheng Biotech planed to use a small amount of its own funds to carry out technical renovations on the existing succinic acid project (50,000 t/a) and malic acid project (50,000 t/a).
In Q1 2025, the citric acid industry saw its profitability slashed due to rising raw material costs.
The USD/CNY exchange rate in this period is 7.1775, sourced from the People's Bank of China on 1 April, 2025. Except for special instructions, all prices involved in this period include VAT.
- Huaheng Biotech announces expansion plan to boost fund-raising efficiency
- Shandong Ensign's 2024 performance reflects positive changes amid market shifts
- Jindan Technology's 2024 transformation: revenue up, net profit down
- Ex-works prices of acidity regulators in China, Q1 2025
- Citric acid profit slumps in Q1, market may stabilize or see slight dip in Q2 2025
- Exports of acidity regulators and raw materials in China, Q4 2024
- Citric acid exports fluctuate but still move forward in 2024
- Jindan Technology's products exported to U.S. face higher tariffs
- Shandong Ensign's 700,000 t/a green intelligent upgrade project for citric acid completes
- Anhui Enlogics' large health natural product production line
- Thailand's fifth anti-dumping sunset review on China's citric acid
- India makes final ruling on sodium citrate imports from China


